GREENLAND MINES LTD Temporary Equity, Aggregate Amount of Redemption Requirement
GREENLAND MINES LTD (GRML) had Temporary Equity, Aggregate Amount of Redemption Requirement of $18.82 million as of 2024-03-31, per its 10-Q filed 2024-05-23.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement · last filed 2024-05-23
- 2024-03-31: Temporary Equity, Aggregate Amount of Redemption Requirement $18.82M.
- 2023-12-31: Temporary Equity, Aggregate Amount of Redemption Requirement $18.56M.
- 2022-12-31: Temporary Equity, Aggregate Amount of Redemption Requirement $117.36M.
| Period end | Temporary Equity, Aggregate Amount of Redemption Requirement |
|---|---|
| 2024-03-31 | $18.82M 10-Q · filed 2024-05-23 |
| 2023-12-31 | $18.56M 10-Q · filed 2024-05-23 |
| 2022-12-31 | $117.36M 10-Q · filed 2024-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |